Triple-negative breast cancer (TNBC) lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) and accounts for 10% to 20% of the newly diagnosed breast cancer cases (1, 2). Here, ERBB2 is linked to breast carcinoma.